Author:
Storck Martin,Krankenberg Hans
Publisher
Springer Berlin Heidelberg
Reference56 articles.
1. Ayoayns V, Ricco B, Bartelink MEL et al (2017) ESC Guidelines for diagnosis and treatment of vascular diseases. Eur J Vasc Endovasc Surg 55:305–368
2. Adam DJ, Beard JD, Cleveland T et al (2005) Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet (London, England) 366:1925–1934
3. Bosiers M, Torsello G, Gissler HM et al (2009) Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study. J Endovasc Ther 16:261–269
4. Bosiers M, Deloose K, Callaert J et al (2011) Results of the Protege EverFlex 200-mm-long nitinol stent (ev3) in TASC C and D femoropopliteal lesions. J Vasc Surg 54:1042–1050
5. Bosiers M, Peeters P, Tessarek J et al (2013) The Zilver(R) PTX(R) Single Arm Study: 12-month results from the TASC C/D lesion subgroup. J Cardiovasc Surg (Torino) 54:115–122